Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Preeclampsia Prevention in Pregnant Women With Type 1 Diabetes
NCT03570632Phase 4Completed
- Start
- Jul 2019
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liquid metformin (Aspargo Labs) in hypertensive disorders of pregnancy (HDP). Started Jul 2019; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
hypertensive disorders of pregnancy (HDP)
Beyond the preview
Go deeper on NCT03570632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03570632.